When CXCR4 expression was reduced, there was a notable decrease in the number of circulating ovarian cancer cells, indicating that the SDF1/CXCR4 pathway might also be involved in blood-borne dissemination (33, 34). Here, CXCR4 is linked to ovarian carcinoma.